We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Low-Cost Technique Detects Rotavirus

By LabMedica International staff writers
Posted on 22 Oct 2014
A new measurement method that increases the capacity to detect biological substances such as Rotavirus using optical biosensors has been discovered and patented.

The system will enhance the detection capacity of small concentrations of Rotavirus due to a new way to assess the biosensing response applied to an interferometric device allowing the detection of both the presence of the virus and its antibody.

Scientists at the Universidad Politécnica de Madrid (Spain) have focused their interests on label-free optical biosensors that do not require the presence of enzymes that fix either the substance to be detected or the marker responsible for any detectable physical phenomenon. These biosensors consist of smooth or micro-nano textured surfaces made with a polymer whose surface has been chemically treated to be similar to a bioreceptor.

Once the surface is coated by the bioreceptor, the biosensor is sensitive and selective to a determined type of biomolecule. When the substance to detect is recognized by a bioreceptor this substance produces a change on its optical response or transduction. This change is usually the movement of the maximum or minimum position of the interferometric pattern. An easy interferometric system based on two Fabry Perot interferometers was tested. One interferometer is used as a reference and the other one captures the substance or virus. Besides, different options of data are analyzed as an alternative to the traditional position shift of the endpoints. This system is easy to install in compact devices and can be used by non-expert users.

The investigators have proved that by using transduction as a variable, the variation of emitted overall intensity at intervals of specific wave length, the sensitivity and detection limit of these biosensors can be significantly improved. All this can reach truly competitive levels for such a simple design. By using the proposed device and reading procedure, they could detect the presence of anti-Rotavirus in blood plasma or anti-Rotavirus as water contaminant. Due to its low cost compared to other methods such as enzyme-linked immunosorbent assay, this technique constitutes a promising way to reduce child mortality in developing countries.

Related Links:

Universidad Politécnica de Madrid



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.